pemetrexed multitarget antifolate Search Results


u-2 os  (ATCC)
99
ATCC u-2 os
U 2 Os, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pemetrexed+multitarget+antifolate/atcc___htb-96?v=ATCC
Average 99 stars, based on 1 article reviews
u-2 os - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
lambda light chain antibody / lambda antibody  (NSJ Bioreagents)
99
NSJ Bioreagents lambda light chain antibody / lambda antibody
Lambda Light Chain Antibody / Lambda Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pemetrexed+multitarget+antifolate/nsj+bioreagents___v2153?v=NSJ+Bioreagents
Average 99 stars, based on 1 article reviews
lambda light chain antibody / lambda antibody - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
multitarget antifolate  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals multitarget antifolate
<t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
Multitarget Antifolate, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pemetrexed+multitarget+antifolate/pmc02907593-170-5-13?v=MultiTarget+Pharmaceuticals
Average 90 stars, based on 1 article reviews
multitarget antifolate - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
pemetrexed  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals pemetrexed
<t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
Pemetrexed, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pemetrexed+multitarget+antifolate/pmc07780021-142-4-4?v=MultiTarget+Pharmaceuticals
Average 90 stars, based on 1 article reviews
pemetrexed - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
saos-2  (ATCC)
98
ATCC saos-2
<t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
Saos 2, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pemetrexed+multitarget+antifolate/atcc___htb-85?v=ATCC
Average 98 stars, based on 1 article reviews
saos-2 - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier
multitargeted antifolate mta  (AstraZeneca ltd)
90
AstraZeneca ltd multitargeted antifolate mta
<t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
Multitargeted Antifolate Mta, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pemetrexed+multitarget+antifolate/pm12057154-67-11-7?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
multitargeted antifolate mta - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Gemcitabine monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer

Journal: Clinical Evidence

Article Title: Pancreatic cancer

doi:

Figure Lengend Snippet: Gemcitabine monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer

Article Snippet: , , Subgroup analysis , Gemcitabine monotherapy v gemcitabine plus other cytotoxic agent (multitarget antifolate, pemetrexed, or topoisomerase inhibitors irinotecan or exatecan) , Overall survival: 4 RCTs, 1404 people; HR 0.99; P = 0.80; no further data reported.

Techniques:

Gemcitabine monotherapy versus gemcitabine-based combinations for non-resectable (locally advanced or advanced) pancreatic cancer

Journal: Clinical Evidence

Article Title: Pancreatic cancer

doi:

Figure Lengend Snippet: Gemcitabine monotherapy versus gemcitabine-based combinations for non-resectable (locally advanced or advanced) pancreatic cancer

Article Snippet: , , Subgroup analysis , Gemcitabine monotherapy v gemcitabine plus other cytotoxic agent (multitarget antifolate, pemetrexed, or topoisomerase inhibitors irinotecan or exatecan) , Overall survival: 4 RCTs, 1404 people; HR 0.99; P = 0.80; no further data reported.

Techniques: